疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

( {, o/ P  B6 y7 f4 qhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
7 ?4 n1 i) B) E! ]+ m
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
; N5 }. O3 \( M1 b, P, s  t5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
! s4 N; M; E" N/ R* X2 R9 Ulicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
5 }; I4 A- G: ]" ]' y% f! OSECTION 2: Licensed vaccines
4 |' l5 a' ?& R6 M# Y2 o; F  e7 x9 Adenovirus vaccines 113
3 m4 {, r* p: Y' D- w6 a9 I10 Anthrax vaccines 127
* f5 I9 C& ?6 [0 k. t* W11 Cholera vaccines 141
' t3 X4 l2 Y1 t12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
8 f+ s9 i8 [  I, u0 T1 W14 Hepatitis A vaccines 183
$ a2 `# t# p. l; d+ w15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
8 J: f" {) w# S* X+ `17 Inactivated influenza vaccines 257
4 V- A6 l* ~3 W5 Z18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
; u5 c, {1 R$ U! m' ]% D20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
4 J( W/ Z7 C3 \3 U0 B2 A24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
# \' c9 w' g; i+ M26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
. J# Z8 r7 D- B+ U0 N1 J6 r3 @  J  N29 Rabies vaccines .646
+ D2 y( U1 J- `30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
7 C1 c+ A7 y$ T7 O3 f8 p37 Varicella vaccine 837
38 Yellow fever vaccine 870
+ a: I: m3 M  {) r39 Zoster vaccine 969
40 Combination vaccines 981
/ k* f4 r. p7 b" E( k! ZSECTION 3: Vaccines in development and new vaccine strategies
' D  w* {% Y8 ~; K# F8 z41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
5 b- m* H! S8 [& h' C43 Cytomegalovirus vaccines 1032
& M) F9 w$ L4 a: q% p44 Dengue vaccines 1042
/ Q( b8 Y7 j' K) ^45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
* Q+ c0 _; t- N+ I  |. ^47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
# \; B! e' f# q" N4 `. y% v50 Herpes simplex virus vaccines 1090
) x# r& b! y' u/ g, }51 Human immunodeficiency virus vaccines 1097
4 c3 r' u9 d; c% ]" k  R52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
/ m) e  V0 T( l2 x4 r4 w: G60 Technologies for making new vaccines 1182
# W7 [5 J8 C  i* W. M/ y61 Alternative vaccine delivery methods 1200
: l* A, B. q8 R% d* D62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
8 z5 N5 M( o# k) c) @5 N* X3 l& K$ O* g, d65 Vaccines for international travel 1270
2 l. n8 n6 b& \  y! z% W3 J$ L7 p66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
: e6 R$ y5 D- ~, \" z68 Immunization in Europe . 1334
: _/ L5 m8 _4 G% W8 w2 V69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
$ t% }& t. p3 f, i. E71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
8 u/ E7 B% N" n# T" {* u73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
  \7 P6 f! p* \( W! N75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
2 u* f4 {6 w* |+ j78 Ethics 1508
5 [, m2 Y; o: e+ D" Q4 B6 B

; m, M6 s% ^% [. m3 [

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

+ q! h7 c4 j1 t' nVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

, V/ O8 O' t/ o# [, a* }$ D; V  rhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
9 Y: N- V/ m1 s5 R+ f0 b
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
, _* I1 L) X% X& x1 O. ?' d( u7 o3 The vaccine industry 33
0 x: t; j, G6 q; B1 H7 G: M4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 |8 S) |2 J; Q6 Z& z* L7 R/ P6 Vaccine additives and manufacturing residuals in the United States:
: y: U. ^/ h4 ?/ {* r/ G' Ilicensed vaccines 71
7 Passive immunization 80
. m: @& P: T4 x0 R# a8 General immunization practices 88
/ @8 U- ?1 g$ G; `# I9 k( mSECTION 2: Licensed vaccines
* G! D$ g( E. p9 Adenovirus vaccines 113
( l1 a) `: l, S8 H6 C6 Y10 Anthrax vaccines 127
$ T! ?7 ~5 m. m( p11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
7 r+ i( S7 J6 q& R14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
! c& m+ }3 l( I  ^; M0 j16 Human papillomavirus vaccines 235
+ D( U( H. ?* W$ z, h17 Inactivated influenza vaccines 257
9 P7 b$ Q, o5 C0 _  E18 Influenza vaccine-live 294
. I5 ?$ R8 g; E- \" B4 Z( S19 Japanese encephalitis vaccines 312
/ U8 t- V) v; u9 ]4 h4 J  L+ @- K20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
! H/ l0 i- _+ x: l- M/ G26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
" u7 T( Z, E$ p. V0 E+ K28 Poliovirus vaccine-live 598
# R  J3 E' D% L7 i# h. J, Q( N/ l3 Z29 Rabies vaccines .646
& u" h8 X& s# i3 |+ }" Z30 Rotavirus vaccines . 669
31 Rubella vaccine 688
2 @9 G0 n4 E( i7 A32 Smallpox and vaccinia 718
2 \: X+ o* Z0 W9 J33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
" H# m: Q, {% K8 T8 d35 Tuberculosis vaccines 789
: S$ `# ^( H* N+ H1 m% c36 Typhoid fever vaccines 812
37 Varicella vaccine 837
/ d4 v8 F2 O- V38 Yellow fever vaccine 870
3 u2 [2 U2 K# y! X. s5 a39 Zoster vaccine 969
; M, A" |2 J' ^40 Combination vaccines 981
! b0 e1 {8 N# c4 x+ nSECTION 3: Vaccines in development and new vaccine strategies
4 K) L3 G9 F7 U( j  w9 k8 `! y' L41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
, B$ \% C  y3 A9 Q( X- H) p, m  r1 `43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
4 q( o% e5 ]- W! P" p3 b3 Y# I45 Diarrhea caused by bacteria 1052
8 C7 [: F' l4 r& o46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
, `$ j  i% ?. V* c" |9 C/ l50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
% W  Z3 R, x" c, z52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
5 w9 h  I+ v$ k' s- p" l1 }54 Noninfectious disease vaccines 1138
+ Z6 I3 x# X3 a/ s% z& F55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
0 L& X. O1 i5 x( E% {; j# I59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
$ G5 U0 `4 X, f61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
3 I+ p# R  L8 @7 v# n: aSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
5 W5 \* O' g2 {3 m64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
5 o. G( E/ S" C1 y( S66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
" y  {5 h7 z- |- i* Q67 Immunization in the United States 1310
2 F# M+ w2 }1 I% U+ A68 Immunization in Europe . 1334
$ j& r0 p, @6 I- O69 Immunization in the Asia-Pacific region 1353
' x" |# g: E; l7 G2 G70 Immunization in developing countries 1369
' p; ?0 k2 |0 D: @% T71 Community immunity 1395
& P( E6 ?0 A) V; J6 E. k0 w72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
( b; c. E2 ]9 _  d$ }* t* J1 l74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
9 f; p8 h2 r% `7 Y% o78 Ethics 1508
2 }1 H( A" g: B4 J
" I2 t- r0 M, u. V, V

casarett

Vaccines, 6e, 2012
8 q" B% i! e, C* M" E
Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
7 x5 I2 Y; z" c0 \, P2 ]' HLanguage: English
ISBN-10: 1455700908
4 m7 ~7 L, s5 E/ P  YSize: 52.3mb (original pdf)

0 d/ ~& F0 }  O2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
" W5 m- {9 e: o# D
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
) L, x$ }! n3 s: P* SGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
8 p( ~# k, c, k- z) ?Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
, c6 e( y7 {) m0 E) y